Evaluation of the effects of curcumin-piperine in reducing Pseudomonas infection and improving clinical outcome in patients with cystic fibrosis - Pending
ongoing trials trial from other registries
Details- 2023
Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Aceragen
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study - Phase 4 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Chris Goss|University of Washington|Medical University of South Carolina|Cystic Fibrosis Foundation|Seattle Children's Hospital
A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa - Phase 1|Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- National Institute of Allergy and Infectious Diseases (NIAID)
Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis - Phase 2|Phase 3 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Wake Forest University Health Sciences|Emory University|University of Minnesota|University of Texas Southwestern Medical Center
The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis â on the search for means of improvement
ongoing trials trial from other registries
Details- 2022
Evaluation the effects of camel milk in spirometry parameters in over 6 yearâs children with Cystic Fibrosis lung disease - Recruiting
ongoing trials trial from other registries
Details- 2022
Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis - Phase 2 - Recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- University of Kansas Medical Center
Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation - Phase 3 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Vertex Pharmaceuticals Incorporated
Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF - Phase 4 - Recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Hospital Infantil de Mexico Federico Gomez